Salve Therapeutics

Salve Therapeutics

Biotechnology, 461 W 6th St, Los Angeles, California, 90731, United States, 11-50 Employees

salvetherapeutics.com

  • LinkedIn

phone no Phone Number: +16*********

Who is SALVE THERAPEUTICS

Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use. Better viral delivery methods would expand ...

Read More

map
  • 461 W 6th St, Los Angeles, California, 90731, United States Headquarters: 461 W 6th St, Los Angeles, California, 90731, United States
  • 2022 Date Founded: 2022
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7373; 8711 | NAICS Code: 541330 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SALVE THERAPEUTICS

Salve Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Salve Therapeutics

Answer: Salve Therapeutics's headquarters are located at 461 W 6th St, Los Angeles, California, 90731, United States

Answer: Salve Therapeutics's phone number is +16*********

Answer: Salve Therapeutics's official website is https://salvetherapeutics.com

Answer: Salve Therapeutics's revenue is $100 Million to $250 Million

Answer: Salve Therapeutics's SIC: 7373; 8711

Answer: Salve Therapeutics's NAICS: 541330

Answer: Salve Therapeutics has 11-50 employees

Answer: Salve Therapeutics is in Biotechnology

Answer: Salve Therapeutics contact info: Phone number: +16********* Website: https://salvetherapeutics.com

Answer: Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use. Better viral delivery methods would expand the available pharmacopeia to produce precision medicines for intractable and incurable genetic diseases. We are building VirCAD (Virus Computer-Aided Design), an HPC-powered, cloud-accessible, AI/ML-capable bioCAD platform to mine, design, model and test new viral drugs for improved cell and gene therapies, vaccines, oncolytics, antibiotics and other categories. These modalities will treat the many inherited and acquired genetic disorders afflicting patients due to their therapeutic specificity, efficiency, and customizability.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access